BNP Paribas Financial Markets’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.5M | Buy |
23,622
+16,751
| +244% | +$7.73M | ﹤0.01% | 1504 |
|
|
2026
Q1 | $3.3M | Sell |
6,871
-1,448
| -17% | -$741K | ﹤0.01% | 2334 |
|
|
2025
Q4 | $4.67M | Sell |
8,319
-6,242
| -43% | -$3.54M | ﹤0.01% | 2104 |
|
|
2025
Q3 | $7.49M | Buy |
14,561
+7,808
| +116% | +$3.41M | ﹤0.01% | 1725 |
|
|
2025
Q2 | $2.12M | Sell |
6,753
-9,383
| -58% | -$2.82M | ﹤0.01% | 2423 |
|
|
2025
Q1 | $4.92M | Sell |
16,136
-38,249
| -70% | -$12.9M | ﹤0.01% | 1823 |
|
|
2024
Q4 | $18.1M | Sell |
54,385
-25,554
| -32% | -$8.67M | 0.01% | 1071 |
|
|
2024
Q3 | $26.7M | Buy |
79,939
+38,427
| +93% | +$14.6M | 0.02% | 740 |
|
|
2024
Q2 | $17.1M | Sell |
41,512
-12,779
| -24% | -$5.06M | 0.01% | 847 |
|
|
2024
Q1 | $21.9M | Buy |
54,291
+28,510
| +111% | +$10M | 0.02% | 730 |
|
|
2023
Q4 | $7.9M | Sell |
25,781
-2,958
| -10% | -$798K | 0.01% | 1150 |
|
|
2023
Q3 | $6.96M | Buy |
28,739
+14,812
| +106% | +$3.79M | 0.01% | 1071 |
|
|
2023
Q2 | $3.34M | Sell |
13,927
-19,238
| -58% | -$4M | ﹤0.01% | 1451 |
|
|
2023
Q1 | $6.24M | Buy |
33,165
+14,673
| +79% | +$3.03M | 0.01% | 1131 |
|
|
2022
Q4 | $3.93M | Sell |
18,492
-2,783
| -13% | -$556K | 0.01% | 1435 |
|
|
2022
Q3 | $3.34M | Buy |
21,275
+3,192
| +18% | +$509K | 0.01% | 1592 |
|
|
2022
Q2 | $2.71M | Buy |
18,083
+14,000
| +343% | +$2.03M | ﹤0.01% | 1571 |
|
|
2022
Q1 | $668K | Sell |
4,083
-4,404
| -52% | -$726K | ﹤0.01% | 2584 |
|
|
2021
Q4 | $1.85M | Buy |
8,487
+4,232
| +99% | +$886K | ﹤0.01% | 2106 |
|
|
2021
Q3 | $805K | Buy |
4,255
+488
| +13% | +$89K | ﹤0.01% | 2496 |
|
|
2021
Q2 | $665K | Sell |
3,767
-2,956
| -44% | -$510K | ﹤0.01% | 2399 |
|
|
2021
Q1 | $1.1M | Buy |
6,723
+229
| +4% | +$35K | ﹤0.01% | 2090 |
|
|
2020
Q4 | $904K | Buy |
6,494
+2,141
| +49% | +$270K | ﹤0.01% | 2087 |
|
|
2020
Q3 | $486K | Buy |
4,353
+2,110
| +94% | +$244K | ﹤0.01% | 2229 |
|
|
2020
Q2 | $209K | Sell |
2,243
-9,363
| -81% | -$797K | ﹤0.01% | 2470 |
|
|
2020
Q1 | $852K | Buy |
11,606
+4,827
| +71% | +$419K | ﹤0.01% | 2026 |
|
|
2019
Q4 | $570K | Buy |
6,779
+1,914
| +39% | +$148K | ﹤0.01% | 2378 |
|
|
2019
Q3 | $409K | Buy |
4,865
+1,812
| +59% | +$137K | ﹤0.01% | 2324 |
|
|
2019
Q2 | $200K | Sell |
3,053
-2,116
| -41% | -$122K | ﹤0.01% | 2623 |
|
|
2019
Q1 | $305K | Buy |
5,169
+4,915
| +1,935% | +$294K | ﹤0.01% | 2435 |
|
|
2018
Q4 | $13.4K | Sell |
254
-455
| -64% | -$25K | ﹤0.01% | 3247 |
|
|
2018
Q3 | $42.5K | Buy |
709
+116
| +20% | +$6.34K | ﹤0.01% | 3108 |
|
|
2018
Q2 | $25.5K | Sell |
593
-1,314
| -69% | -$53.1K | ﹤0.01% | 3398 |
|
|
2018
Q1 | $66.6K | Buy |
1,907
+475
| +33% | +$17.4K | ﹤0.01% | 3398 |
|
|
2017
Q4 | $51.9K | Buy |
1,432
+438
| +44% | +$15.4K | ﹤0.01% | 3646 |
|
|
2017
Q3 | $31.7K | Sell |
994
-63
| -6% | -$1.92K | ﹤0.01% | 3372 |
|
|
2017
Q2 | $30.7K | Buy |
1,057
+860
| +437% | +$24.1K | ﹤0.01% | 3436 |
|
|
2017
Q1 | $5.88K | Sell |
197
-83
| -30% | -$2.68K | ﹤0.01% | 3282 |
|
|
2016
Q4 | $10.1K | Sell |
280
-11
| -4% | -$366 | ﹤0.01% | 3454 |
|
|
2016
Q3 | $8.69K | Buy |
+291
| New | +$8.5K | ﹤0.01% | 3239 |
|
Other funds holding MEDP
WA
BNP Paribas Financial Markets's MEDP Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its Medpace (MEDP) stake by 244% in Q2 2026, buying an estimated $7.73M and bringing the position to 23,622 shares worth $12.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1504.
BNP Paribas Financial Markets first reported a position in MEDP in Q3 2016 and has held it in 40 quarters since. The position peaked at $26.7M in Q3 2024. 661 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- BNP Paribas Financial Markets held 23,622 shares of Medpace worth $12.5M as of Q2 2026.
- BNP Paribas Financial Markets bought 16,751 Medpace shares in Q2 2026, an estimated $7.73M.
- Medpace made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1504 holding.
- BNP Paribas Financial Markets first reported a position in Medpace in Q3 2016 and has held it in 40 quarters since.
- BNP Paribas Financial Markets's Medpace position peaked at $26.7M in Q3 2024.
- 661 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.